Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C  by Sindić, Aleksandra et al.
Kidney International, Vol. 68 (2005), pp. 1008–1017
Uroguanylin and guanylin regulate transport of mouse cortical
collecting duct independent of guanylate cyclase C
ALEKSANDRA SINdIC´, ANA VELIC, CANDAN BAS¸OGLU, JOCHEN R. HIRSCH, BAYRAM EDEMIR,
MICHAELA KUHN, and EBERHARD SCHLATTER
Universita¨tsklinikum Mu¨nster, Medizinische Klinik und Poliklinik D, Experimentelle Nephrologie, Mu¨nster, Germany;
and Institut fu¨r Pharmakologie und Toxikologie, Mu¨nster, Germany
Uroguanylin and guanylin regulate transport of mouse cortical
collecting duct independent of guanylate cyclase C.
Background. Electrolyte and water homeostasis mostly de-
pend on differentially regulated intestinal and renal transport.
Guanylin and uroguanylin were proposed as first hormones
linking intestinal with renal electrolyte and water transport,
which is disturbed in pathophysiology. Guanylate cyclase C is
the intestinal receptor for these peptides, but in guanylate cy-
clase C–deficient mice renal effects are retained. Unlike for the
intestine the sites of renal actions and cellular mechanisms of
guanylin peptides are still unclear.
Methods. After first data on proximal tubular effects in this
study their effects are examined in detail in mouse cortical col-
lecting duct (CCD). Effects of guanylin peptides on principal
cells of isolated mouse CCD were studied by slow whole-cell
patch-clamp analysis, reverse transcription-polymerase chain
reaction (RT-PCR), and microfluorimetric measurements of in-
tracellular Ca2+.
Results. Guanylin peptides depolarized or hyperpolarized
principal cells. Whereas 8-Br-cyclic guanosine monophos-
phate (8-Br-cGMP) hyperpolarized, 8-Br-cyclic adenosine
monophosphate (8-Br-cAMP) depolarized principal cells. All
effects of guanylin peptides were inhibited by Ba2+. Hyper-
polarizations were blocked by clotrimazole or protein kinase
G (PKG) inhibition, suggesting an involvement of basolateral
Ca2+- and cGMP-dependent K+ channels. Effects remained in
CCD isolated from guanylate cyclase C–deficient mice. Depo-
larizations were inhibited by arachidonic acid or inhibition of
phospholipase A2 (PLA2), but not by protein kinase A (PKA)
inhibition.
Conclusion. These results suggest the existence of two signal-
ing pathways for guanylin peptides in principal cells of mouse
CCD. One pathway is cGMP- and PKG-dependent but not
mediated by guanylate cyclase C, the second involves PLA2
and arachidonic acid. The first pathway most likely leads to an
activation of the basolateral K+-conductance while the latter
probably results in decreased activity of ROMK channels in
the luminal membrane.
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Na+ and K+ homeostasis are essential for many cells
to function normally and require tightly controlled distri-
butions of these ions between intracellular and extracel-
lular fluid. The kidney and especially the principal cells
of the collecting duct are the key site for regulation of
this electrolyte homeostasis under physiologic and even
more important under pathophysiologic situations. Reg-
ulation of Na+ and K+ conductances in the luminal or
basolateral membrane of cortical collecting duct (CCD)
has severe impacts on whole body functions and is con-
trolled by hormones such as aldosterone and antidiuretic
hormone [1].
The endogenous guanylin peptides, guanylin and
uroguanylin [2, 3] regulate electrolyte and water trans-
port in intestine via guanylate cyclase C and in addition,
stimulate kaliuresis, natriuresis, and diuresis in the kid-
neys via signaling pathways which are still not completely
understood [4–6]. Oral salt intake leads to higher natri-
uresis than intravenous salt load, suggesting an intestinal-
renal link in the control of salt excretion after oral intake
[7]. This effect is decreased in uroguanylin-deficient mice
[8] and urinary concentrations of uroguanylin and cyclic
guanosine monophosphate (cGMP) are increased in rats
fed with a high salt diet [9]. As the intestine secretes
guanylin peptides into the blood they are viewed as in-
testinal natriuretic peptides [10].
In the intestine activation of guanylate cyclase C by
guanylin peptides leads to an increase of intracellular
cGMP which inhibits the Na+/H+ exchanger [11], acti-
vates protein kinase G (PKG) and modulates the activity
of phosphodiesterase III and thereby cyclic adenosine
monophosphate (cAMP)/protein kinase A (PKA) sig-
naling [12]. PKG and PKA activate the cystic fibrosis
transmembrane regulator (CFTR) located at the luminal
membrane of enterocytes, leading to Cl− and HCO3−
secretion [13–16]. The heat-stable enterotoxin of
Escherichia coli, which is similar in structure to guanylin
and uroguanylin, also activates guanylate cyclase C, how-
ever, in an unregulated fashion and leads to secretory
diarrhea [17–19].
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In the kidney, guanylin and uroguanylin increase the
secretion of Na+, K+, and water without changes in
glomerular filtration rate, kidney blood flow, or urine os-
molality [4–6]. A guanylate cyclase–dependent signaling
pathway for guanylin and uroguanylin exists in a proxi-
mal tubule cell line from opossum kidney [20]. Opossum
guanylate cyclase is localized in the luminal membrane of
cortical tubules [20, 21]. However, in guanylate cyclase
C–deficient mice guanylin peptides still cause natriure-
sis, kaliuresis, diuresis, and increase urinary cGMP, sug-
gesting the existence of a signaling pathway for guanylin
peptides in the kidney which is guanylate cyclase C in-
dependent [6]. In a human proximal tubule cell line we
demonstrated that uroguanylin activates two signaling
pathways: one involving guanylate cyclase C leading to
increased cellular cGMP, the other one involves the acti-
vation of a pertussis toxin-sensitive G protein [22]. In a
limited functional study using isolated human CCD, we
recently reported first evidences again for an activation of
a G protein–coupled receptor which leads to activation of
phospholipase A2 (PLA2) by guanylin and uroguanylin
[23]. Given these first data from the human CCD, the dif-
ficulty in obtaining human tissue and since principal cells
of CCD are involved in hormone-regulated urinary ex-
cretion of Na+, K+, and water, we here examined effects
of guanylin peptides in principal cells of mouse CCD in
more detail.
We propose the existence of two signaling pathways:
one involving cGMP, but guanylate cyclase C indepen-
dent, a second pathway involving activation of PLA2 and
arachidonic acid, like in human principal cells. Both path-
ways interact primarily with K+ conductances and, thus,
are able to modulate salt excretion differently [e.g., to
aldosterone or aginine vasopressin (AVP)].
METHODS
Animals
In this study 2-month-old male C57BL mice and guany-
late cyclase C–deficient mice [24, 25] were used. They
were fed with a standard rodent chow ad libitum. Mice
were anesthetized with xilazine (Sigma, Taufkirchen,
Germany), 15 mg/kg body weight, and ketamine (Sigma),
300 mg/kg body weight, intraperitoneally. Experiments
were approved by a governmental committee on animal
welfare and were performed in accordance with national
animal protection guidelines.
Isolation of nephron segments
For reverse transcription-polymerase chain reaction
(RT-PCR) nephron segments were isolated using the
procedure described previously [26, 27]. Shortly, corti-
cal pieces of mouse kidney were incubated in modified
Eagle’s medium (MEM) containing 5 mmol/L glycine,
480 IU/mL trypsin inhibitor from soybean, 50 IU/mL
DNAse, and 178 IU/mL collagenase type 2 (Worthington
Biochemical Corp., Freehold, NJ, USA) for 60 to 100
minutes at 37◦C with aeration (95% O2 and 5% CO2).
Specific nephron segments were collected in MEM with
5 mmol/L glycine under 50× magnification at 4◦C. For
patch clamp experiments and measurements of intracel-
lular Ca2+, CCDs were isolated using the procedure de-
scribed by us for rat kidney [26, 28]. The kidney was
perfused in situ with MEM supplemented by 5 mmol/L
glycine, 26 mmol/L NaHCO3, 107 IU/mL collagenase
type 4 (Worthington Biochemical Corp.), and 1 IU/mL
protease. Small cortical pieces of the kidney were further
incubated with supplemented MEM and 54 IU/mL colla-
genase type 4 and 0.5 IU/mL protease at 37◦C for 15 min-
utes with aeration (95% O2 and 5% CO2). Isolated CCD
tubules were collected under 50× magnification at 4◦C in
the above medium without enzymes but with 50 g/L albu-
min and 1 lmol/L deoxycorticosterone acetate (DOCA
solution). These CCD tubules were used in some experi-
ments, when basolateral localization of receptors was ex-
amined. To gain access to the luminal membrane CCD
clusters were prepared from these tubules by further in-
cubation in Ca2+-free solution (MEM) [5 mmol/L glycine
and 5 mmol/L ethyleneglycol tetraacetate (EGTA)] [27].
Clusters were incubated at 37◦C in the DOCA solution
for at least 2 hours before the experiments to increase the
Na+ conductance.
RT-PCR
Total RNA from mouse nephron segments or
glomeruli was isolated using the RNeasy Kit (Qiagen,
Hilden, Germany). cDNA was synthesized by reverse
transcriptase (BD Biosciences, Heidelberg, Germany)
and subjected to the PCR reaction. To detect mRNA
for guanylate cyclase G and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (used as a positive control
for the PCR reaction) the following primers were used
in the first PCR reaction: guanylate cyclase G sense 5′-
ACCATCTTCTTCTCTGACATCG-3′and guanylate cy-
clase G antisense 5′-CTTCTTCCTCCGTAAACTCAG-
3′. In the second nested PCR reaction the primers guany-
late cyclase G sense 5′-CACAAAGCTGTGTTCCCT
CA-3′ and guanylate cyclase G antisense 5′-CTTTCAG
CCAGAAGGTCGTC-3′ with a fragment length of 503
bp were used. For GAPDH detection the sense primer
5′-TGGCCTTCCGTGTTCCTACC-3′ and antisense
primer 5′-GGTCCTCAGTGTAGCCCAAGATG-3′,
fragment length 136 bp, were used. Reaction conditions
were as follows: (1) 5 minutes at 94◦C, (2) 30 seconds at
94◦C, (3) 30 seconds at 56◦C, (4) 1 minute at 72◦C, 30
cycles (steps 2 to 4), and (5) 10 minutes at 72◦C. PCR
products were analyzed by agarose gel electrophoresis
and verified by sequence analyses.
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Patch clamp studies
Membrane voltages (Vm) of principal cells in CCD
clusters and tubules were measured using the slow whole-
cell patch clamp technique [29]. CCD segments were
held in a perfusion chamber on an inverted micro-
scope (Axiovert 10) (Zeiss, Gottingen, Germany) with
a glass holding pipette. A Ringer type solution con-
taining 145 mmol/L NaCl, 1.6 mmol/L K2HPO4, 0.4
mmol/L KH2PO4, 5 mmol/L D-glucose, 1 mmol/L MgCl2,
and 1.3 mmol/L calcium gluconate (pH 7.4) was used
as bathing solution. All experiments were performed
at 37◦C with a bath perfusion rate of 10 mL/min.
Patch clamp pipettes were filled with 95 mmol/L potas-
sium gluconate, 30 mmol/L KCl, 4.8 mmol/L Na2HPO4,
1.2 mmol/L NaH2PO4, 5 mmol/L D-glucose, 1.3 mmol/L
calcium gluconate, 1.03 mmol/L MgCl2, and 1 mmol/L
adenosine triphosphate (ATP) (pH 7.2). To this solution
160 lmol/L nystatin was added to permeabilize the mem-
brane under the pipette [30]. Vm was measured with a
patch clamp amplifier (U. Fro¨be, Physiologische Institut,
Freiburg, Germany) and recorded continuously on a pen
recorder (WeKa graph, Kaltbrunn, Switzerland).
Fluorescence measurements of intracellular Ca2+
CCD clusters were fixed on the inverted microscope
as described above and incubated with the fluorescence
dye fura2-acetoxymethyl ester (5 lmol/L) for 40 min-
utes. CCD clusters were excited at 340 nm, 360 nm, and
380 nm. The fluorescence ratio (340/380) was calculated.
A Ringer-type solution containing 145 mmol/L NaCl,
1.6 mmol/L K2HPO4, 0.4 mmol/L KH2PO4, 5 mmol/L
D-glucose, 1 mmol/L MgCl2, and 1.3 mmol/L calcium
gluconate (pH 7.4) was used. The experiments were per-
formed at 37◦C with a bath perfusion rate of 10 mL/min.
The experimental setup was controlled and results ana-
lyzed with a computer system as described before [31].
Biochemical reagents
MEM was obtained from Gibco (Karlsruhe,
Germany), human guanylin and uroguanylin from
Peptide Institute (Osaka, Japan), and wortmannin,
KT5720, KT5823, clotrimazole, arachidonic acid, and
heat-stable enterotoxin of E. coli from Calbiochem
(Schwalbach, Germany). AACOCF3 was purchased
from Biomol (Hamburg, Germany), all other chemicals
from Merck (Darmstadt, Germany) or Sigma.
Statistical analyses
Student paired and unpaired t tests were used where
appropriate with each effect compared with its own av-
eraged pre- and postcontrol values. Data are presented
as mean values ± SEM. The number of experiments is
given in brackets. P < 0.05 was set as significance level.
RESULTS
Effects of guanylin peptides on Vm
Principal cells of mouse CCD clusters were function-
ally identified by hyperpolarizations caused by 1 lmol/L
amiloride (−7.8 ± 0.4 mV) (N = 119), an inhibitor of
epithelial Na+ channels (ENaC) present in CCD only
in principal cells [30]. Basal Vm of principal cells was
−68.1 ± 0.9 (N = 192). Increasing the extracellular K+
concentration by 15 mmol/L depolarized cells by 27.2 ±
0.6 mV (N = 191). The distribution of basal Vm and
the correlation of Vm with depolarizations caused by in-
creases in the K+ concentration are shown in Figure 1.
At low concentrations guanylin depolarized, while
uroguanylin and heat-stable enterotoxin of E. coli led
to hyperpolarizations of principal cells of CCD clusters
(Fig. 2). At 10 nmol/L in 41% of the measurements
guanylin induced in addition a hyperpolarization of
−3.2 ± 0.4 mV (N = 15). On the other hand, uroguanylin
or heat-stable enterotoxin of E. coli at 10 nmol/L in ad-
dition depolarized cells in 50% and 31% by 3.1 ± 0.3 mV
(N = 45) and 2.8 ± 0.4 mV (N = 12), respectively. In only
4% of all experiments principal cells (6 from 171 cells)
did not respond to guanylin peptides at 10 nmol/L and
these results were not taken into consideration. The re-
sponse to guanylin peptides at 10 nmol/L showed a clear
bimodal distribution. This is demonstrated in Figure 3A
for uroguanylin and in Figure 3B for all three peptides
together. These bimodal effects of guanylin peptides did
not correlate with the baseline voltages (data not shown).
Receptors for guanylin and uroguanylin are localized in
the luminal membrane
Guanylate cyclase receptors for guanylin peptides are
localized in the luminal membrane of enterocytes [32]
and of renal proximal tubular cells of human and opos-
sum kidney [20, 22]. To determine if this is the case also
in principal cells of mouse CCD, results from CCD clus-
ters (the perfusion buffer having access to both, lumi-
nal and basolateral membranes) were compared with
results of nonperfused CCD tubules (access only to the
basolateral membrane). Since the amiloride effect could
not be used to identify principal cells in CCD tubules,
in those experiments we chose the cells with high basal
membrane potential; therefore, basal Vm and depolariza-
tions caused by an increase in extracellular K+ showed
no differences between these two preparations (data not
shown). However, guanylin and uroguanylin (10 nmol/L)
induced significant changes in Vm of principal cells only
in CCD clusters while in CCD tubules no significant ef-
fects of guanylin and uroguanylin were observed (Fig. 4),
suggesting a localization of receptors for guanylin and
uroguanylin on the luminal membrane of mouse princi-
pal cells. Based on these observations, CCD clusters were
used in all further experiments.
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Fig. 1. General electrophysiologic characteristics of principal cells of
mouse cortical collecting duct (CCD) clusters. (A) Frequency distribu-
tion of basal Vm measured by the slow whole-cell patch clamp tech-
nique. (B) Correlation between Vm and depolarizations caused by an
increase in extracellular K+ by 15 mmol/L (r = −0.76).
Guanylin peptides regulate K+ conductances
Depolarizations and hyperpolarizations of principal
cells can be caused by changes in Na+ or K+ conduc-
tances. To investigate the involvement of K+ conduc-
tances in both effects of guanylin peptides, we used Ba2+
as K+ channel blocker. Ba2+ (1 mmol/L) depolarized
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Fig. 2. Effects of guanylin (GN) peptides on Vm of principal cells of
mouse cortical collecting duct (CCD) clusters This figure depicts only
that type of responses for each peptide, which was seen at low con-
centrations, opposite voltage effects at 10 nmol/L for all peptides are
omitted for clarity (for details see the text). All data represent the mean
± SEM with the number of experiments given in brackets. ∗Statistically
significant effect (P < 0.05). UGN is uroguanylin; STa is heat-stable
enterotoxin of Escherichia coli.
mouse principal cells by 27.6 ± 1.5 (N = 30). All effects of
guanylin peptides on Vm of principal cells of CCD clusters
were completely abolished in the presence of Ba2+, sug-
gesting the involvement of changes in K+ conductances
in both, the depolarizing and hyperpolarizing responses
of the peptides (Fig. 5).
PKG is involved in the signaling pathway
To characterize the possible signaling mechanisms of
guanylin peptides in mouse principal cells, we investi-
gated the role of cGMP, the second messenger for these
peptides in the intestine. The membrane permeable ana-
logue 8-Br-cGMP (100 lmol/L) caused hyperpolariza-
tions of principal cells of CCD clusters which were, like
the effects of guanylin peptides, inhibited by 1 mmol/L
Ba2+ (control −2.8 ± 0.4 mV and +Ba2+ −1.1 ± 0.3 mV)
(six paired experiments). Furthermore, the inhibitor of
PKG, KT5823 (1 lmol/L), inhibited the hyperpolariza-
tions caused by 10 nmol/L uroguanylin (uroguanylin
−2.2±0.1 mV and uroguanylin in the presence of KT5823
1.1 ± 0.4 mV) (five paired experiments). These results
suggest that the cGMP/PKG signaling system mediates
the hyperpolarization of principal cells in response to
uroguanylin.
In principal cells of rat CCD cellular cGMP stimulates
intermediate conductance and Ca2+-dependent K+ chan-
nels at the basolateral membrane via PKG [28, 33, 34].
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Fig. 3. Frequency distribution of the effects of uroguanylin (UGN) at
10 nmol/L (A) and of all three peptides taken together (B) on Vm of
mouse principal cells of cortical collecting duct (CCD) clusters mea-
sured by the slow whole-patch clamp technique. GN is guanylin; STa is
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Therefore, the involvement of these K+ channels in hy-
perpolarizations induced by uroguanylin or heat-stable
enterotoxin of E. coli in mouse principal cells of CCD
clusters was examined. As an inhibitor of intermediate
conductance Ca2+-dependent K+ channels clotrimazole
(10 lmol/L) was used which depolarized principal cells
by 4.2 ± 1.2 mV (N = 17). Hyperpolarizations caused by
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Fig. 4. Effects of guanylin (GN) peptides on Vm of principal cells of
mouse cortical collecting duct (CCD) clusters and nonperfused CCD
tubules. Guanylin and uroguanylin (UGN) (10 nmol/L) showed effects
only in principal cells of clusters where they could approach the luminal
membrane but not in tubules where they could only approach the baso-
lateral membrane. All data represent the mean ± SEM with the number
of experiments given in parentheses. ∗P < 0.05 between the effects of
guanylin peptides on Vm of principal cells in clusters and tubules.
uroguanylin or heat-stable enterotoxin of E. coli (both
10 nmol/L) were inhibited by clotrimazole (uroguanylin
−2.9 ± 0.5 mV and uroguanylin in the presence of
clotrimazole 0.8 ± 0.6 mV) (five paired experiments)
(heat-stable enterotoxin of E. coli −3.3 ± 0.4 mV and
heat-stable enterotoxin of E. coli in the presence of clotri-
mazole 1.0 ± 0.6 mV) (three paired experiments).
Guanylate cyclase C is not the receptor
for guanylin peptides
Guanylate cyclase C is the receptor for guanylin pep-
tides in the intestine, but guanylate cyclase C–specific
mRNA could not be detected in mouse CCD [24]. To
further test the hypothesis that guanylate cyclase C is
not the receptor mediating the responses of CCD to
these peptides, the effects of guanylin peptides in princi-
pal cells of CCD clusters isolated from guanylate cyclase
C–deficient mice were tested. Basal Vm, depolarizations
caused by Ba2+ (1 mmol/L), or by an increase in extra-
cellular K+ concentration, and hyperpolarizations caused
by amiloride (1 lmol/L) showed no significant difference
between principal cells of CCD isolated from guanylate
cyclase C–deficient mice or from wild-type mice. The
cGMP-dependent signaling pathway for guanylin pep-
tides inducing hyperpolarizations was unaltered in princi-
pal cells from guanylate cyclase C–deficient mice (Fig. 6),
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Fig. 6. Effects of guanylin (GN) peptides in principal cells of cortical
collecting duct (CCD) clusters isolated from guanylate cyclase C (GC-
C)–deficient mice. Guanylin peptides still hyperpolarized principal cells
of guanylate cyclase C–deficient mice. All data represent the mean ±
SEM with the number of experiments given in parentheses. P < 0.05
between effects of guanylin peptides in principal cells isolated from
wild-type animals compared to those from guanylate cyclase–deficient
mice. UGN is uroguanylin; STa is heat-stable enterotoxin of Escherichia
coli.
supporting the hypothesis that guanylate cyclase C is not
involved in the signaling pathway of guanylin peptides in
principal cells of mouse CCD. So far, only one particu-
late guanylate cyclase has been detected in rat principal
cells and that is the orphan receptor guanylate cyclase
G [35]. mRNA for guanylate cyclase G was present in
mouse CCD (Fig. 7).
M 1 2 3 4 5 6 7 8
500 bp
Fig. 7. mRNA for guanylate cyclase G (GC-G) in mouse kidney. M,
marker; 1, cortex; 2, medulla; 3, papilla; 4 and 5, cortical collecting duct
(CCD); 6 and 7, positive control [glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) whole kidney and CCD], and 8, negative control (no
cDNA).
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Fig. 8. Effects of guanylin (GN) peptides on intracellular Ca2+ concen-
tration in mouse cortical collecting duct (CCD) clusters. Guanylin pep-
tides (10 nmol/L) did not significantly increase the fura2 fluorescence
ratio. Prostanglandin E2 (PGE2, 100 nmol/L) was used as positive con-
trol. Data represent the mean ± SEM with the number of experiments
given in brackets. UGN is uroguanylin; STa is heat-stable enterotoxin
of Escherichia coli.
Effects of guanylin peptides are independent of Ca2+,
PKA, and phosphoinositol-3 kinase (PI3K)
An additional possible signaling pathway for guanylin
peptides involves Ca2+ and protein kinase C (PKC) [36].
However, Ca2+ does not change electrolyte transport
in rat CCD [31], but so far this has not been exam-
ined in mouse CCD. Therefore, we tested the involve-
ment of Ca2+ in the signaling pathway of guanylin pep-
tides. All three peptides failed to significantly increase
the Ca2+ concentration in mouse CCD clusters (Fig. 8).
Prostaglandin E2 (PGE2), which was used as a positive
control, increased Ca2+ but did not significantly change
Vm of principal cells (0.8 ± 0.4 mV) (N = 7), as shown be-
fore for rat CCD [31]. Thus, neither depolarizations nor
hyperpolarizations caused by guanylin peptides involved
changes in Ca2+ concentrations in mouse principal cells.
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Antidiuretic hormone depolarizes principal cells via
increasing intracellular cAMP concentrations and activa-
tion of PKA in rat CCD [30]. 8-Br-cAMP (100 lmol/L)
also led to a small depolarization of mouse principal
cells in CCD clusters by 1.9 ± 0.1 mV (N = 4), but the
PKA inhibitor, KT5720 (1 lmol/L) was not able to in-
hibit depolarizations caused by uroguanylin (10 nmol/L)
(uroguanylin 2.8 ± 0.2 mV and uroguanylin in the pres-
ence of KT5720 3.2±0.7 mV) (three paired experiments),
indicating that cAMP and PKA are not involved in the
signaling pathway of these peptides. Further, wortmannin
(1 lmol/L), an inhibitor of PI3K, did not change depolar-
izations caused by uroguanylin (10 nmol/L) (uroguanylin
1.9 ± 0.3 mV and uroguanylin in the presence of wort-
mannin 2.2 ± 0.3 mV) (five paired experiments) indicat-
ing that also this kinase is not involved in the signaling
pathway of uroguanylin.
Inhibition of PLA2 inhibited depolarizations
caused by uroguanylin
It is known that arachidonic acid inhibits ROMK chan-
nels located at the luminal membrane of principal cells
of rat CCD [37]. Recently we reported that arachidonic
acid is involved in the signaling pathway of guanylin
peptides in principal cells of human CCD [23]. Here,
arachidonic acid (10 lmol/L) led to depolarizations of
principal cells in CCD clusters (5.5 ± 1.3 mV) (N = 12).
Since the effects of uroguanylin were due to changes in
K+ conductances and arachidonic acid inhibited depolar-
izations caused by uroguanylin (uroguanylin 10 nmol/L
3.4 ± 0.2 mV and uroguanylin in the presence of arachi-
donic acid −0.6 ± 1.3 mV) (five paired experiments)
the involvement of PLA2 in the signaling pathway of
uroguanylin was further tested using AACOCF3, an in-
hibitor of PLA2. Depolarizations, but not hyperpolariza-
tions caused by uroguanylin (10 nmol/L) were inhibited
by 5 lmol/L AACOCF3 (Fig. 9), indicating an involve-
ment of PLA2 in the signaling pathway of uroguanylin in
mouse principal cells leading to depolarizations.
DISCUSSION
Guanylate cyclase C was the first receptor to be identi-
fied for guanylin peptides. In 1993 the existence of a bind-
ing site for heat-stable enterotoxin of E. coli in intestinal
cells (ICE-6) which has no guanylate cyclase activity was
proposed [38]. Furthermore, in the intestine of guany-
late cyclase C–deficient mice 10% of the binding sites
for heat-stable enterotoxin of E. coli compared to wild-
type mice were still present [32, 39]. In these guanylate
cyclase C–deficient animals guanylin peptides increased
cGMP in the urine and still produced natriuresis, kali-
uresis, and diuresis in the kidney [6]. On the contrary,
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Fig. 9. Effects of AACOCF3, an inhibitor of phospholipase A2 (PLA2)
on uroguanylin (UGN) effects. Depolarizations but not hyperpolariza-
tions of principal cells of cortical collecting duct (CCD) clusters caused
by uroguanylin (10 nmol/L) were inhibited by AACOCF3 (5 lmol/L).
Data represent the mean ± SEM with the number of experiments
given in parentheses (paired experiments). ∗P < 0.05 between effects of
uroguanylin in the presence of AACOCF3 compared to control effects.
in uroguanylin-deficient mice the ability to respond to
an oral NaCl load by an increased renal Na+ excretion
was impaired. These animals even developed hyperten-
sion [8]. To further understand the role of these peptides
in renal physiology and pathophysiology detailed studies
on the tubular level are urgently needed. The action of
guanylin peptides on transport in proximal tubular cells
and their possible mechanism was demonstrated in oposs-
sum and human proximal tubular cell lines [20, 22]. Re-
cently we were able to report limited functional evidence
for specific effects of guanylin peptides in freshly isolated
human CCD [23], the segment which is responsible for
the fine tuning of renal electrolyte and water excretion.
As regular supply of human renal tissue to isolate CCD
segments for detailed functional studies is extremely dif-
ficult, we investigated the effects of these peptides on Vm
of principal cells of freshly isolated mouse CCD in more
detail. To functionally identify principal cells versus in-
tercalated cells we again used the effect of amiloride, an
inhibitor of ENaC, which in CCD is only present in prin-
cipal cells and therefore leads to hyperpolarizations of
these cells [23, 30].
Guanylin mainly depolarized and uroguanylin as well
as heat-stable enterotoxin of E. coli hyperpolarized prin-
cipal (Fig. 2). At 10 nmol/L, comparable to findings in the
human proximal tubule cell line [22] all three peptides
provoked two types of voltage responses depolarizations
or hyperpolarizations of principal cells of CCD clusters.
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There was no apparent difference in any of the other ob-
served properties between cells responding in either way
and two near Gaussian distributions of voltage responses
were observed (Fig. 3). From these data we have to con-
clude that two distinct signaling mechanisms for these
peptides exist also in principal cells of the collecting duct.
As there is no evidence for two types of principal cells
in CCD neither in the literature nor in this study, the
relative expression and/or activity of the two pathways
probably determines which effect of these peptides dom-
inates at higher concentrations. In contrast, at low con-
centrations guanylin only depolarized while uroguanylin
and heat-stable enterotoxin of E. coli only hyperpolarized
Vm suggesting different sensitivities of the two signaling
pathways for guanylin peptides. This hypothesis is further
supported by the fact that in 4% of the experiments no
changes in Vm were observed which could indicate iden-
tical induction of both opposing effects. The reason for
such dual effects of guanylin peptides on mouse princi-
pal cells stays unclear. Further it is reasonable to believe
that effects of guanylin peptides in native intact tubu-
lus would be much higher than in used clusters because
of the short circuit and loss of the difference in Vm be-
tween luminal and basolateral side of the principal cell.
The same effect was shown for antidiuretic hormone and
cAMP in rat CCD [30]. All effects of guanylin peptides
were completely inhibited by Ba2+ (Fig. 5), suggesting the
involvement of changes in K+ conductances in the signal-
ing pathways of guanylin peptides in mouse principal cells
again comparable to the situation in the human proximal
tubule cell line [22] or human CCD [23]. Thus, depolariza-
tions should be due to a decrease, hyperpolarizations to
an increase in a K+ conductance. Depolarizations could
be also caused by activations and hyperpolarizations by
inhibition of Na+ channels (amilorid effect). Since effects
of guanylin peptides were completely inhibited by Ba2+,
we are suggesting that there is no involvement of electro-
genic ion transport other than K+ or effects are to small
to be detected with methods used in this study.
Receptors for guanylin peptides are localized in the lu-
minal membrane of enterocytes and proximal tubular cell
lines [20, 22, 32]. When guanylin peptides were tested in
CCD clusters, where the peptides could reach the lumi-
nal and basolateral membrane and in nonperfused CCD
tubules, where only the basolateral membrane could be
accessed, effects of guanylin and uroguanylin on Vm were
only observed in CCD clusters (Fig. 4). These results
clearly indicate that receptors for guanylin peptides are
localized solely in the luminal membrane also of princi-
pal cells of mouse CCD. A luminal action of uroguanylin
in the CCD in vivo is very likely as this peptide is not
degraded in the tubular lumen and is found in urine [3,
40]. Therefore, circulating uroguanylin can modify CCD
transport after glomerular filtration and tubular concen-
tration along the nephron. In addition, uroguanylin could
be secreted into the tubular lumen as its mRNA was
found in proximal tubules [24]. Guanylin, on the other
hand, is rapidly degraded and does not reach the urine
[4, 41]; it could, however, act as an autocrine or paracrine
hormone as its mRNA is found in the CCD [24].
Since cGMP is a second messenger for guanylin pep-
tides in the intestine [39] and in proximal tubule cells [20,
22] we determined if cGMP also plays a crucial role in
the signaling pathway of guanylin peptides in principal
cells of mouse CCD. Similar to rat principal cells [28], the
membrane-permeable cGMP-analogue, 8-Br-cGMP, hy-
perpolarized mouse principal cells. In rat, cGMP activates
PKG which stimulates intermediate conductance and
Ca2+-dependent K+ channels in the basolateral mem-
brane of principal cells [28, 33, 34]. In line with this model,
inhibition of PKG by KT5823 and inhibition of these
Ca2+-dependent K+ channels by clotrimazole, both in-
hibited the hyperpolarizations caused by guanylin pep-
tides. The prime candidate receptor for these effects on
cellular cGMP by guanylin peptides would be guanylate
cyclase C; however, mRNA for this receptor was neither
present in mouse nor rat CCD [24, 35]. In addition, hy-
perpolarizations caused by guanylin peptides were still
present in principal cells of CCD isolated from guanylate
cyclase C–deficient mice (Fig. 6). In the same guanylate
cyclase C–deficient mice guanylin peptides still increased
the cGMP concentration in urine, indicating an involve-
ment of another guanylate cyclase than guanylate cyclase
C [6]. The only particulate guanylate cyclase found in
principal cells of rat CCD was guanylate cyclase G [35].
For this receptor so far no ligands are known, however,
mRNA for this receptor was also detected in mouse CCD
in this study (Fig. 7).
The second, cGMP-independent signaling pathway for
these peptides apparently involves PLA2 and arachi-
donic acid, since both arachidonic acid and the inhibitor
of PLA2 blocked depolarizations caused by uroguanylin
(Fig. 9). It is known that arachidonic acid inhibits ROMK
channels located in luminal membrane of principal cells
[37]. Thus, guanylin peptides most likely depolarized
principal cells by inhibiting ROMK channels via acti-
vation of PLA2 and arachidonic acid. Similar signaling
pathway for guanylin peptides is shown in principal cells
of human CCD [23]. To confirm involvement of ROMK
channels in signaling pathways of guanylin peptides it is
necessary to perform single channel recordings.
This study suggests the existence of two signaling path-
ways for guanylin peptides in mouse principal cells, in
contrast to the existence of only one signaling pathway
for these peptides in human principal cells [23]. The sig-
naling cascade only seen in mouse CCD, leading to hy-
perpolarizations, most likely involves activation of PKG
and stimulation of basolateral K+ channels. The other sig-
naling pathway is characterized by a reduction in the K+
conductance of principal cells by an inhibition of ROMK
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channels. This signaling pathway is probably identical to
that already described for principal cells of the human
CCD [23]. The resulting depolarization will reduce the
driving force for Na+ and consecutive water reapsorp-
tion and thus, could at least in part explain the natriuresis
and diuresis induced by guanylin peptides. Interestingly,
guanylin and uroguanylin are first endogenous ligands
which regulate transport along the collecting duct by pri-
marily acting on the K+ channels of the CCD and, thus,
differ from the classic regulatory pathways primarily in-
terfering with Na+ or water channels. Other parts of the
nephron like the proximal tubule, the thick ascending
limb or the medullary collecting duct probably contribute
to these effects as well and in addition to the kaliuresis
seen in vivo with these peptides. The nature of the recep-
tors involved and the factors determining the direction of
responses remains to be elucidated.
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